Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview (2023)
- Authors:
- USP affiliated authors: FERREIRA, LUIS CARLOS DE SOUZA - ICB ; FAVARO, MARIANNA TEIXEIRA DE PINHO - ICB
- Unidade: ICB
- DOI: 10.3390/pharmaceutics15041197
- Subjects: MICROBIOLOGIA; PROTEÍNAS; PROTEÍNAS RECOMBINANTES; MEDICAMENTO; NANOPARTÍCULAS; AMINOÁCIDOS; POLIPEPTÍDEOS; GLICOPROTEÍNAS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Pharmaceutics
- ISSN: 1999-4923
- Volume/Número/Paginação/Ano: v. 15, n. 4, art. 1197, p. 1-16, 2023
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
CORCHERO, José Luis et al. Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview. Pharmaceutics, v. 15, n. 4, p. 1-16, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15041197. Acesso em: 28 dez. 2025. -
APA
Corchero, J. L., Favaro, M. T. P., Márquez-Martínez, M., Lascorz, J., Martínez-Torró, C., Sánchez, J. M., et al. (2023). Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview. Pharmaceutics, 15( 4), 1-16. doi:10.3390/pharmaceutics15041197 -
NLM
Corchero JL, Favaro MTP, Márquez-Martínez M, Lascorz J, Martínez-Torró C, Sánchez JM, López-Laguna H, Vázquez E, Ferrer-Miralles N, Villaverde A, Parladé E, Ferreira LC de S. Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview [Internet]. Pharmaceutics. 2023 ; 15( 4): 1-16.[citado 2025 dez. 28 ] Available from: https://doi.org/10.3390/pharmaceutics15041197 -
Vancouver
Corchero JL, Favaro MTP, Márquez-Martínez M, Lascorz J, Martínez-Torró C, Sánchez JM, López-Laguna H, Vázquez E, Ferrer-Miralles N, Villaverde A, Parladé E, Ferreira LC de S. Recombinant proteins for assembling as Nano- and Micro-Scale materials for drug delivery: a host comparative overview [Internet]. Pharmaceutics. 2023 ; 15( 4): 1-16.[citado 2025 dez. 28 ] Available from: https://doi.org/10.3390/pharmaceutics15041197 - Bivalent DNA vaccines confer prophylactic and therapeutic effect on HPV-16 murine tumor
- Expression of a treptococcal M protein epitope fused at different sites of flagellin (FliCd) as an approach for the development of bivalent vaccines based on attenuated Salmonella strains
- Evaluation of the prophylactic and therapeutic effects of anti-cancer DNA vaccine encoding the HPV-16 E7 oncoprotein genetically fused to the HSV-1 GD
- Protective immune response in mice immunized with the GP43-derived P10 peptide and Salmonella enterica FLICD flagellin
- Immunomodulatory properties of the enterotoxigenic Escherichia coli type IIa heat-labile enterotoxin (LT-IIa) in mice immunized via the intradermal route
- Protective Immune Responses to enteropathogenic Escherichia coli Strain with a New Recombinant Bacillus subtilis Vaccine strains
- Modulação da resposta imune pela listeriolisina o (LLO) expressa por linhagens recombinantes de bacillus subtilis empregadas como vetores vacinais vivos
- Evidence of ball-and-chain transport of ferric enterobactin through FepA
- Effect of gender on training-induced vascular remodeling in SHR
- Enhanced anti-tumor effect of a gene gun-delivered DNA vaccine encoding the human papillomavirus type 16 oncoproteins genetically fused to the herpes simplex virus glycoprotein D
Informações sobre o DOI: 10.3390/pharmaceutics15041197 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
